Storia in 3 fonti

Molbio IPO Day 2: GMP hits at 17% listing gains. Should you bid?

The Molbio Diagnostics IPO entered its second day with strong investor interest, as the grey market premium (GMP) climbed to 17% from 15% earlier. The issue was subscribed 83% on Day 1, with retail investors subscribing to 77% of their quota. The Rs 939.70-crore IPO comprises a Rs 200-crore fresh issue and Rs 739.70 crore OFS.

Raccontata da

economictimes.indiatimes.com

thehindubusinessline.com

m.economictimes.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

economictimes.indiatimes.comStai leggendo3 g fa

Molbio IPO Day 2: GMP hits at 17% listing gains. Should you bid?

Molbio Diagnostics IPO subscribed 83% at Rs 807/share, raises Rs 939.70 crore with 17% grey market premium. Indian molecular diagnostics company reports 42% revenue growth YoY; demonstrates healthcare automation/biotech scalability in Asia market.

originale

m.economictimes.com5 g fa

Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?

Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics valuations are broadly in line with industry benchmarks. The company is also being offered at a discount to the average P/E…

Timeline cronologica

sabato 8 agosto 2026·economictimes.indiatimes.com
Molbio Diagnostics collects Rs 281 cr from anchor investors ahead of IPO
Molbio Diagnostics has successfully attracted Rs 281.5 crore from anchor investors ahead of its much-anticipated initial public offering. The company aims to raise between Rs 904…
sabato 8 agosto 2026·thehindubusinessline.com
Molbio IPO: Should Investors Subscribe?
Molbio's IPO presents a growth opportunity for investors, but high valuations may pose risks amid strong market competition.

Molbio IPO Day 2: GMP hits at 17% listing gains. Should you bid?

Confronto fonti

Molbio IPO Day 2: GMP hits at 17% listing gains. Should you bid?

Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?

Timeline cronologica

Molbio Diagnostics collects Rs 281 cr from anchor investors ahead of IPO

Molbio IPO: Should Investors Subscribe?

Dhoot Transmission, Molbio Diagnostics IPOs see over 70 times subscription on closing day

World Bank's IFC, HDFC AMC invest in Molbio Diagnostics' Rs 281 crore IPO anchor round

Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?

Molbio Diagnostics IPO: Analyst recommendations—should you subscribe or give it a miss?

Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?

Molbio Diagnostics IPO opens today: GMP at 15% — Check price band. Should you subscribe?

Molbio IPO Day 2: GMP hits at 17% listing gains. Should you bid?

Screening India’s healthcare diagnostics market

Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?

Dhoot Transmission, Molbio Diagnostics IPOs see over 70 times subscription on closing day

Molbio Diagnostics IPO allotment likely today; GMP at 20% — Here’s how to check status